Wanyi Lin

机构：National Taiwan University, Shanghai Jiao Tong University, Xiamen University, Renji Hospital, Center for Clinical Studies, Qingzhou City People's Hospital, Zhongshan Hospital of Xiamen University, National Institutes of Health Clinical Center · ORCID：0009-0009-2992-1456

发表论文 41 篇 · 总被引 656 次 · h-index 12

代表论文

• Autophagy-associated circRNA circCDYL augments autophagy and promotes breast cancer progression (2020 · Molecular Cancer · 被引 277)
• circCDYL2 promotes trastuzumab resistance via sustaining HER2 downstream signaling in breast cancer (2022 · Molecular Cancer · 被引 96)
• Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer (2019 · The Oncologist · 被引 27)
• A 10-miRNA risk score-based prediction model for pathological complete response to neoadjuvant chemotherapy in hormone receptor-positive breast cancer (2022 · Science China Life Sciences · 被引 20)
• Bulk RNA Sequencing With Integrated Single-Cell RNA Sequencing Identifies BCL2A1 as a Potential Diagnostic and Prognostic Biomarker for Sepsis (2022 · Frontiers in Public Health · 被引 15)
• Prognostic and predictive value of the combination of TOP2A and HER2 in node-negative tumors 2 cm or smaller (T1N0) breast cancer (2020 · Breast Cancer · 被引 12)